There are generic versions of Actos (pioglitazone) available, and they are sold in three strengths. The FDA has determined that these generic medications are equivalent to brand-name Actos. However, the generic versions may have different inactive ingredients, which may cause problems for some people.
Actos® (pioglitazone hydrochloride) is a prescription medication that has been licensed to treat type 2 diabetes. It is part of a group of diabetes medications called thiazolidinediones.
Brand-name Actos is manufactured by Takeda Pharmaceuticals. However, generic versions are also available.
Generic Actos is available in the following strengths:
- Pioglitazone 15 mg tablets
- Pioglitazone 30 mg tablets
- Pioglitazone 45 mg tablets.
It is made by various manufacturers, such as:
- Mylan Pharmaceuticals, Inc.
- Teva Pharmaceuticals USA.
The version made by Teva is actually an "authorized generic," meaning that it is the real, brand-name medication that is just packaged and sold under a generic name. It is exactly the same as Actos in every way (it is even made by Takeda), except it comes in a bottle with a generic name.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic Actos versions currently available have an "AB" rating, meaning they should be equivalent to Actos. The authorized version from Teva has not been given a rating, and this makes sense, because it is the brand-name version that has been relabeled, so testing is unnecessary.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.